AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

HPV vaccine can prevent early in situ cervical ca: prevents CIN2, CIN3 related to HPV 16, 18.(News)

OB GYN News

| November 01, 2005 | Boschert, Sherry | COPYRIGHT 2005 International Medical News Group. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

SAN FRANCISCO -- A multinational study of 11,502 young women showed for the first time that a vaccine for human papillomavirus can prevent precancerous cervical lesions and early in situ cervical cancers, Laura A. Koutsky, Ph.D., reported.

The recombinant vaccine against HPV types 6, 11, 16, and 18 was 100% effective in preventing cervical intraepithelial neoplasia (CIN) grades 2 and 3 and adenocarcinoma in situ (AIS) related to HPV 16 or 18 in 5,301 women who completed a three-shot vaccination regimen and were negative for the HPV types at the start and end of vaccinations. HPV 16 and 18 cause approximately 70% of invasive cervical cancers worldwide.

Among 5,258 females who received three placebo shots, 1 developed AIS, 15 developed CIN3, and 5 developed CIN2 during an average 17-month follow-up, Dr. Koutsky said at the annual meeting of the Infectious Diseases Society of America.

The data came from a planned interim analysis of the ongoing Females United to Unilaterally Reduce Endo-Ectocervical Disease study (FUTURE II), a randomized, double-blind, phase III clinical trial of the vaccine made by Merck & Co., said Dr. Koutsky, professor of epidemiology at the University of Washington, Seattle. Dr. Koutsky has received grants and research funding from Merck, which funded the trial.

By year's end, the company plans to apply for approval to market the vaccine under the trade name Gardasil.

A secondary analysis intended to reflect more real-world conditions found the vaccine was 97% effective in preventing CIN2/CIN3 and AIS in women who received at least one of the three intended vaccinations. In this secondary analysis, 1 of 5,736 women in the vaccine group became infected with HPV 16 and developed CIN2. Among 5,766 women in the placebo group, 4 developed AIS, 23 developed CIN3, and 9 developed CIN2 related to HPV 16 or 18 over a 2-year follow-up starting 30 days after the first vaccination.

CIN2/CIN3 and AIS are accepted as surrogates for invasive cervical cancer for research purposes by regulatory agencies.

Related articles from newspapers, magazines, journals, and more
National HPV & Cervical Cancer Campaign Announces New Patient Guidelines...
Press release article from: PR Newswire January 7, 2002 700+ words
...Cancer Month, the National HPV & Cervical Cancer Campaign announced new...the causal link between HPV and cervical cancer and the importance of regular...clinicians. The National HPV & Cervical Cancer Campaign's recommendations...
Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer...
Press release article from: PR Newswire October 6, 2008 700+ words
...human papillomavirus (HPV) and cervical cancer has spurred lifesaving...the causal role of the HPV virus in cervical cancer spurred research teams...high-risk types of HPV associated with cervical cancer. Cervical cancer is...
HPV Cervical Cancer Vaccine Has Potential to Reduce Cancer Deaths by...
News wire article from: The America's Intelligence Wire June 8, 2006 700+ words
...following statement on the HPV cervical cancer vaccine: Alan Kaye, chairman...States. Worldwide, having a cervical cancer/HPV vaccine implemented in most...for anyone desiring their cervical cancer/HPV vaccine. Imagine, over the...
The role of males in transmission of HPV infections and cervical cancer...
Magazine article from: Infectious Diseases in Obstetrics and Gynecology Bosch, Xavier January 1, 2006 700+ words
...levels of cervical HPV infection and cervical cancer in their partners...in the case of cervical cancer strongly influence...epidemiology of HPV-associated disease...play a role in HPV prevalence within populations. Cervical cancer rates in women...
Cervical Cancer - Digene HPV Test Rekindles Hope for Women.
Newspaper article from: Vanguard (Nigeria) April 7, 2009 700+ words
...Since the cause of cervical cancer - HPV - is known and women...cancers and deaths from cervical cancer," QIAGEN's HC2 HPV testing platform was...international experts in cervical-cancer prevention should now adapt HPV testing for widespread...
New Data Show Cervarix(TM), GSK's HPV 16/18 Cervical Cancer Candidate Vaccine,...
Press release article from: PR Newswire June 5, 2006 700+ words
...vaccinated with GSK's cervical cancer candidate vaccine...response against HPV 16 and HPV 18...risk of developing cervical cancer due to infection by cancer-causing HPV types. These results...against oncogenic HPV infection to protect them against cervical ...
Cervical cancer risk rises if women with HPV also have herpes infection....
Magazine article from: International Family Planning Perspectives London, S. June 1, 2003 700+ words
...than women without cervical cancer to have HPV-infected cervical...conjunction with HPV infection to modestly...risk of invasive cervical cancer," the investigators...HP V-induced cervical cancer. Herpes lesions may allow HPV easier access to...
STUDY SHOWS HPV TESTING SIGNIFICANTLY CUTS DEATHS FROM CERVICAL CANCER.
News wire article from: AsiaPulse News April 2, 2009 700+ words
...international experts in cervical-cancer prevention should now adapt HPV testing for widespread...and deaths from cervical cancer," QIAGEN's hc2 HPV testing platform...increase access to HPV testing and cervical cancer prevention technologies...
Digene HPV Test, Education and Early Detection Recommended As Effective Methods...
Press release article from: PR Newswire February 11, 1999 700+ words
...Global Solutions to Cervical Cancer Detection and Elimination Revealed at HPV Summit - CHAMONIX...elimination of cervical cancer is within sight. The HPV Summit 1999 has...the benefits of HPV DNA testing in cervical cancer screening programs...
Survey Identifies Communication Gap Between Providers And Patients Regarding...
Press release article from: PR Newswire June 28, 2005 700+ words
...the relationship between HPV and cervical cancer despite the fact that advanced...providers and patients related to cervical cancer and HPV is an issue that is largely...talked to their doctor about HPV and cervical cancer compared to just 18 percent...
For more facts and information, see all results

Source: HighBeam Research, HPV vaccine can prevent early in situ cervical ca: prevents CIN2,...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA